drugset / Trial / NCT06134414
Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
RandomizedParallel-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the efficacy of MY008211A in adult patients with PNH, showing signs of active hemolysis.
Timeline
- Start
- 2025-12
- Primary completion
- 2027-07
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MY008211A | Unknown | 400 mg | Oral |
| Subject | MY008211A | Unknown | 600 mg | Oral |